Myocardial Bridging
Showing 51 - 75 of 5,020
The "MyoThrombus" Study
Recruiting
- Left Ventricular Thrombus
- +3 more
- 18F-GP1 PET/MR
-
Edinburgh, United KingdomRoyal Infirmary Edinburgh
Apr 9, 2021
Aortic Aneurysm, Abdominal, Juxtarenal Aortic Aneurysm, Extent IV Thoracoabdominal Trial (Zenith Fenestrated+ Endovascular Graft
Not yet recruiting
- Aortic Aneurysm, Abdominal
- +3 more
- Zenith Fenestrated+ Endovascular Graft in combination with the BeGraft Balloon-Expandable FEVAR Bridging Stent Graft System
- (no location specified)
Dec 13, 2022
Allergic Rhinitis Trial in Ars-laquenexy, Lille (Nasal Spray)
Recruiting
- Allergic Rhinitis
- Nasal Spray
-
Ars-laquenexy, France
- +5 more
Sep 5, 2022
Out-Of-Hospital Cardiac Arrest, Cardiac Arrest, Cardiac Arrhythmia Trial (ER-REBOA catheter)
Not yet recruiting
- Out-Of-Hospital Cardiac Arrest
- +5 more
- ER-REBOA catheter
- (no location specified)
Oct 4, 2023
Myocardial Remodeling After Acute Myocardial Infarction Using
Recruiting
- Myocardial Infarction
-
Beijing, Xicheng, ChinaXuanwu Hospital, Capital Medical University
Sep 27, 2023
Stenosis, Fusion of Spine (Disease) Trial in Seoul (transforaminal lumbar interbody arthrodesis)
Completed
- Stenosis
- Fusion of Spine (Disease)
- transforaminal lumbar interbody arthrodesis
-
Seoul, Korea, Republic ofKwang Sup Song
Nov 8, 2021
Diphtheria Vaccine Adverse Reaction, Tetanus Vaccine Adverse Reaction, Pertussis Vaccine Adverse Reaction Trial in Bandung
Not yet recruiting
- Diphtheria Vaccine Adverse Reaction
- +4 more
- Recombinant Hepatitis B new Bulk vaccine
- +3 more
-
Bandung, West Java, Indonesia
- +2 more
Jul 29, 2022
Solid Tumor Trial in Shenyang (Intravenous infusion anti-HER2-CAR-T cell)
Not yet recruiting
- Solid Tumor
- Intravenous infusion anti-HER2-CAR-T cell
-
Shenyang, Liaoning, ChinaPhase I Clinical Trials Center Of The First Hospital of China Me
Oct 30, 2023
COVID-19, SARS-CoV-2 Pneumonia Trial in Huai'an (Recombinant COVID-19 vaccine (Sf9 cell))
Not yet recruiting
- COVID-19
- SARS-CoV-2 Pneumonia
- Recombinant COVID-19 vaccine (Sf9 cell)
-
Huai'an, Jiangsu, ChinaJiangsu Provincial Center for Disease Control and Prevention
Jul 19, 2022
Standardized Osteotomy Guides for Free Flap Reconstruction of
Not yet recruiting
- Oral Surgical Procedures
- +2 more
- Reconstruction
- (no location specified)
Feb 9, 2023
B-cell Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia, Relapsed B-cell Acute Lymphoblastic Leukemia
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- +2 more
-
Milwaukee, WisconsinMedical College of Wisconsin
Apr 4, 2022
Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial in Germany (Cyclophosphamide (Non-IMP,
Not yet recruiting
- Acute Myeloid Leukemia, in Relapse
- Acute Myeloid Leukemia Refractory
- Cyclophosphamide (Non-IMP, Lymphodepletion)
- +3 more
-
Ulm, Baden-Württemberg, Germany
- +4 more
Jul 24, 2023
Myocardial Infarction With Non-obstructive Coronary Arteries, Cardiac Shock Wave Therapy Trial in Shanghai (Cardiac Shock Wave
Recruiting
- Myocardial Infarction With Non-obstructive Coronary Arteries
- Cardiac Shock Wave Therapy
- Cardiac Shock Wave Therapy
-
Shanghai, Shanghai, ChinaDepartment of Cardiology, Shanghai Tenth People's Hospital
Jun 29, 2023
Rotator Cuff Tear Arthropathy Trial in Halifax (Bridging Rotator Cuff Reconstruction, Superior Capsular Reconstruction,
Recruiting
- Rotator Cuff Tear Arthropathy
- Bridging Rotator Cuff Reconstruction
- +2 more
-
Halifax, Nova Scotia, CanadaNova Scotia Health Authority
Mar 7, 2022
Coronary Artery Disease Using Noninvasive Myocardial Work
Active, not recruiting
- Noninvasive Myocardial Work
- Coronary Artery Disease
- Transthoracic echocardiography
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital
May 24, 2023
REVIparin-BRIDging-in a General Practice Setting in GErmany
Terminated
- Thromboembolism
-
Berlin, Germany
- +10 more
Mar 17, 2022
Carcinoma Trial (Intravenous infusion anti-CEA-CAR-T cell)
Not yet recruiting
- Carcinoma
- Intravenous infusion anti-CEA-CAR-T cell
- (no location specified)
Aug 22, 2023
Leukemia, Chronic Myelogenous Trial in China (asciminib, best available treatment)
Recruiting
- Leukemia, Chronic Myelogenous
- asciminib
- best available treatment
-
Chongqing City, Chongqing, China
- +23 more
Jan 18, 2023
Cardiovascular Diseases, Myocardial Infarction, Acute Coronary Syndrome Trial in Thessaloníki
Recruiting
- Cardiovascular Diseases
- +3 more
-
Thessaloníki, Central Macedonia, Greece
- +1 more
Mar 30, 2023
Myocardial Infarction Trial in Nantes (Dynamic 99mTc-Tetrofosmin CZT-SPECT)
Not yet recruiting
- Myocardial Infarction
- Dynamic 99mTc-Tetrofosmin CZT-SPECT
-
Nantes, FranceNantes University Hospital
Jul 3, 2023
Mast Cells and Prognosis in Acute Myocardial Infarction
Not yet recruiting
- Inflammation
- +2 more
- Tryptase
- (no location specified)
Apr 5, 2023
Long QT Syndrome, Sinus Bradycardia, Sinus Tachycardia Trial in Taoyuan city (Chang Gung ECG Abnormality Detection Software)
Not yet recruiting
- Long QT Syndrome
- +9 more
- Chang Gung ECG Abnormality Detection Software
-
Taoyuan city, TaiwanChang Gung memorial hospital
Jun 6, 2023
Leukemia, Lymphoid Trial in Chengdu (blinatumomab)
Recruiting
- Leukemia, Lymphoid
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Oct 27, 2023
Acute Anterior ST Segment Elevation Myocardial Infarction Trial (Nivolumab, Placebo)
Not yet recruiting
- Acute Anterior ST Segment Elevation Myocardial Infarction
- Nivolumab
- Placebo
- (no location specified)
Jun 6, 2023
CMR in T2DM: The NSR Cohort
Enrolling by invitation
- Diabetes Mellitus, Type 2
- +4 more
- All subjects will undergo cardiac magnetic resonance imaging with gadolinium contrast and with adenosine myocardial perfusion
-
Slagelse, DenmarkSlagelse Hospital, department of cardiology and endocrinology, m
Jun 13, 2023